Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of the Association of Velcade to R-CHOP in the Treatment of B Cell Lymphoma

NCT00169468 is registered in ClinicalTrials.gov with Lymphoma Study Association as lead sponsor.

NCT NCT00169468
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00169468 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of the Association of Velcade to R-CHOP in the Treatment of B Cell Lymphoma
Lead sponsor
Lymphoma Study Association
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2005
Completion date
January 31, 2006
Enrollment
48 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

b cell lymphoma